IONIS PHARMACEUTICALS INC - Common Stock (IONS)

CUSIP: 462222100

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / Common Stock
Shares outstanding
162,643,196
Total 13F shares
103,265,462
Share change
+103,160,698
Total reported value
$6,394,592,642
Put/Call ratio
129%
Price per share
$61.93
Number of holders
328
Value change
+$6,388,115,622
Number of buys
314

Quarterly Holders Quick Answers

What is CUSIP 462222100?
CUSIP 462222100 identifies IONS - IONIS PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IONS - IONIS PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q4 2015

As of 31 Dec 2015, IONIS PHARMACEUTICALS INC - Common Stock (IONS) was held by 328 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 103,265,462 shares. The largest 10 holders included FMR LLC, Clearbridge Investments, LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BB BIOTECH AG, WADDELL & REED FINANCIAL INC, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, BlackRock Fund Advisors, and FIRST TRUST ADVISORS LP. This page lists 328 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2015 vs Q2 2010 Across Filers

Q2 2010 holders
1
Q4 2015 holders
328
Holder diff
327
Investor Q2 2010 Shares Q4 2015 Shares Share Diff Share Chg % Q2 2010 Value $ Q4 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .